Bacteroides fragilis: Anaerobe, Capsule, Abscesses, Diagnosis, Treatment

A patient has emergency surgery for a burst appendix. The initial infection is brought under control, but about a week later the fever returns, along with abdominal pain and a rising white cell count. A scan shows a walled-off pocket of pus deep in the abdomen, an abscess.

The bowel contents that spilled during the rupture contained many kinds of bacteria, yet one organism dominates this abscess out of all proportion to how common it is in the gut. It builds the abscess wall around itself using a single powerful tool: its capsule. This is Bacteroides fragilis, the most important anaerobe in human infection.

General Characteristics

Bacteroides fragilis is a gram-negative, non-spore-forming, non-motile, pleomorphic rod, appearing as slender rods or coccobacilli. It is an anaerobe, but an unusually hardy one: it tolerates brief exposure to oxygen better than most anaerobes (it is aerotolerant), which matters clinically because it helps the organism survive the journey from a ruptured gut into the tissues and bloodstream.

Here is the central paradox that organizes this whole topic. B. fragilis is only a small fraction of the bacteria in the gut, yet it is the most common anaerobe isolated from clinical infections. It punches far above its numbers. The reason is its virulence factors, above all its capsule, and understanding the capsule explains almost everything about the disease it causes

Figure: Bacteroides fragilis

Habitat

Bacteroides species are among the most abundant organisms in the human large intestine (the gut carries roughly 10¹¹ to 10¹² bacteria per gram of feces, and Bacteroides make up a large share of this). But here is the key point: within the Bacteroides population, B. fragilis itself is a relatively minor member. Despite being a minority in the gut, it causes the majority of Bacteroides infections. The mismatch between how common it is in the gut and how often it causes disease is exactly what its virulence factors explain.

Virulence factors and pathogenesis of Bacteroides fragilis

B. fragilis has several virulence factors, but one stands above the rest.

The capsule: the central weapon

What it is: a polysaccharide capsule surrounding the organism.

Why it matters: the capsule does two things, and together they explain why B. fragilis dominates anaerobic infection.

• It resists phagocytosis. The capsule shields the organism from being engulfed and killed by the host's phagocytes, so B. fragilis survives where other bacteria are cleared.
• It directly promotes abscess formation. This is the unusual and important part. The capsular polysaccharide provokes the host to wall off the infection into an abscess. In other words, the organism actively drives the body to build the very abscess in which it then survives. This is why B. fragilis is so strongly associated with abscesses, out of proportion to its numbers in the gut.

The abscess is a double-edged outcome. It limits spread, but it also protects the bacteria inside from the immune system and from antibiotics, which is why abscesses often need to be drained, not just treated with drugs.

Supporting virulence factors

• Adhesins (fimbriae and agglutinins): help the organism attach to host tissue.
• Aerotolerance (oxygen defense): B. fragilis has enzymes that reduce the toxicity of oxygen, allowing it to survive brief oxygen exposure. This is what lets it survive after spilling from the gut into oxygen-containing tissue long enough to establish infection in an anaerobic pocket.
• Tissue-destroying enzymes: it produces enzymes that damage host tissue, aiding invasion and creating the dead, low-oxygen tissue it thrives in.
• Endotoxin: its lipopolysaccharide is structurally unusual and less potent than the classic endotoxin of organisms such as E. coli.
• Enterotoxin (in some strains): enterotoxigenic B. fragilis strains produce a toxin (fragilysin) that can cause diarrhea.

Putting it together: how infection develops

The normal barrier is the gut wall, which keeps B. fragilis safely inside the bowel. Disease begins when that barrier is broken, by a ruptured appendix, bowel perforation, trauma, or abdominal or pelvic surgery. Gut contents, a mix of many bacteria, spill into normally sterile tissue. B. fragilis survives the oxygen exposure, its tissue-damaging enzymes and the local anaerobic conditions let it grow, and its capsule both protects it and drives the host to wall it off into an abscess. This is why B. fragilis infections are typically intra-abdominal or pelvic, follow a breach of the gut, and form abscesses.

Disease

Following a breach of the gut, B. fragilis causes peritonitis and intra-abdominal abscesses. It also causes pelvic infections and abscesses, and, by spread through the blood, more distant infections including brain abscess and empyema (pus in the pleural space). Enterotoxigenic strains can cause diarrhea.

Figure: Common locations of infections involving anaerobic bacteria(Image source: Koneman, Ref-1)

Because the B. fragilis group lives in the gut, any break in the gut lining, from trauma or gastrointestinal or genitourinary surgery, lets these bacteria enter sterile tissue and cause intra-abdominal infection unless appropriate surgical prophylaxis is given. B.fragilis is most commonly responsible for intra-abdominal abscesses and sepsis but is also involved in gynecological abscesses, skin and soft tissue infections, pericarditis (as a result of hematogenous spread to the heart), bacteremia often associated with malignancies or in postsurgical infections, and rare instances of endocarditis, meningitis, and septic arthritis.

A defining feature of B. fragilis infections is that they are usually polymicrobial. The infection typically contains a mix of gut organisms, with facultative bacteria (such as E. coli) consuming oxygen and creating the anaerobic conditions in which B. fragilis flourishes. The two work together, which is why intra-abdominal infections are treated with cover for both.

Laboratory Diagnosis

All specimens for anaerobic culture must be handled meticulously, because oxygen exposure can kill the anaerobes and cause the culture to fail.

(Note that B. fragilis itself is relatively aerotolerant, which is part of why it is recovered more often than more oxygen-sensitive anaerobes; but good anaerobic technique is still essential for anaerobic cultures in general.)

Accepted specimens

• Tissue bits
• Necrotic materials
• Aspirated body fluids
• Pus in syringes

Unacceptable specimen for anaerobic culture

• gastric washings,
• all swabs
• midstream urine,
• prostatic secretions collected transurethrally,
• feces (except for the recovery of Clostridioides difficile)
• throat, nose, or other oropharyngeal specimens (except specimens obtained from the deep tissue during oral surgery),
• superficial skin, and environmental cultures

Transport

Specimens should be placed immediately into an anaerobic transport medium (such as Robertson cooked meat broth) and taken to the laboratory as soon as possible.

Gram Stain

All clinical specimens from suspected anaerobic infections should be Gram stained and examined for characteristic morphology.

Figure: Gram-negative, Bacteroides fragilis subsp.fragilis (Image source: CDC/ Don Stalons)

Many times in clinical laboratories, anaerobic gram-negative bacilli that grow on Bacteroides fragilis selective media (like Bacteroides bile esculin) may be reported out as “B. fragilis group”; so it is difficult to know how common some of the other members are in infections. With the increased use of molecular methods and MALDI-TOF in the future, we should expect to be able to better determine what species really are involved in clinical infections.

Culture & Identification

Samples should be processed immediately under anaerobic conditions which can be created by various methods. Anaerobic cultures should be performed routinely only on tissues or aspirated fluid/pus.

Never perform anaerobic cultures on specimens from sites that may be contaminated with mucosal flora or feces

Various culture media can be used for the isolation of anaerobes, such as:

• Anaerobic blood agar
• Neomycin blood agar
• Egg yolk agar
• Phenylethyl alcohol agar (PEA)
• BHIS agar: Brain-Heart infusion agar added with supplements, such as vitamin K and hemin
• Bacteroides bile esculin (BBE) agar. This is both selective and differential for the B. fragilis group: the group grows in the presence of bile (which inhibits most other anaerobes) and hydrolyzes esculin, turning the medium dark. Growth on BBE with esculin hydrolysis is a classic presumptive identifier of the B. fragilis group.

Isolates are identified on the basis of

• Colony morphology,
• Gram staining characteristics
• Biochemical tests
• Susceptibility to antibiotic disks
• Gas-liquid chromatography etc.

Antimicrobial susceptibility and treatment

The resistance pattern of the B. fragilis group follows a clear logic. Most isolates produce a beta-lactamase, so they are resistant to penicillins (ampicillin, amoxicillin) and most cephalosporins. This is why ordinary penicillins fail against B. fragilis, an important point, because these are exactly the drugs that might be reached for otherwise.

The reliable choices are the ones that get around the beta-lactamase or act by a different mechanism:

• Metronidazole: highly active and a mainstay for B. fragilis.
• Carbapenems (such as meropenem): reliably active.
• Beta-lactam / beta-lactamase-inhibitor combinations (such as piperacillin-tazobactam or ampicillin-sulbactam): active, because the inhibitor blocks the enzyme.

Two further points matter. First, resistance to clindamycin has increased, so clindamycin is no longer a dependable choice for the B. fragilis group. Second, and just as important as drug choice: abscesses usually need drainage. Because the organism sits inside a walled-off abscess that antibiotics penetrate poorly, source control (surgical or radiological drainage) is often essential, and antibiotics alone may not cure the infection. And because these infections are usually polymicrobial, treatment must also cover the accompanying facultative organisms (such as E. coli).

How to Remember

Key exam facts in one table

Where Students Get Confused

References and Further Readings

1. Tille, P. M. (2022). Bailey & Scott's Diagnostic Microbiology (15th ed.). Elsevier.
2. Procop, G. W., & Koneman, E. W. (2017). Koneman's Color Atlas and Textbook of Diagnostic Microbiology (7th ed.). Wolters Kluwer.
3. Carroll, K. C., Pfaller, M. A., et al. (2020). Murray's Medical Microbiology (9th ed.). Elsevier.
4. Wexler, H. M. (2007). Bacteroides: the good, the bad, and the nitty-gritty. Clinical Microbiology Reviews, 20(4), 593–621.